ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
19 announcements
Abhishek Ashvinbhai Kamdar HUF acquired 5,35,000 shares of Global Longlife Hospital and Research Ltd via the open market. This constitutes a non-promoter stake acquisition.
Global Longlife Hospital and Research has amended its Memorandum of Association to expand its business scope into agricultural and textile trading activities.
Trade Pulse Broking Pvt Ltd acquired a 2.55% stake in Global Longlife Hospital and Research Ltd. The open market purchase increases their total holding to 7.31%.
Promoter Dhruv Jani sold 7,22,000 equity shares of Global Longlife Hospital via open market. This reduced the promoter's stake from 6.89% to 0.01%.
Promoter Dhruv Sureshkumar Jani sold 10,00,000 shares (9.52% stake) of Global Longlife Hospital and Research Limited via open market transactions.
Promoter Dhruv Sureshkumar Jani sold 6,78,000 equity shares of Global Longlife Hospital and Research Ltd via open market. Post-transaction, the promoter's holding decreased to 16.41%.
Global Longlife Hospital and Research Ltd filed its quarterly shareholding pattern as of June 30, 2026. This disclosure is submitted under Regulation 31(1)(b).
Shareholders approved the re-appointment of Mr. Dhruv Jani as Managing Director. His five-year term runs from September 10, 2026 to September 09, 2031.
Global Longlife Hospital held its 15th AGM on June 25, 2026 via video conference. The meeting approved audited results, director re‑appointments and a name change.
Global Longlife Hospital submitted its 15th Annual Report for FY 2025-26. The report includes audited financials showing a net loss of ₹1.72 Crore.
Global Longlife Hospital and Research Limited convened its 15th AGM for June 25, 2026. Key agenda items include director appointments and alteration of the Memorandum of Association.
Global Longlife Hospital re-appointed Mr. Dhruv Jani as Managing Director for five years. The appointment, effective September 2026, remains subject to upcoming shareholder approval.
Global Longlife Hospital and Research Limited appointed M/s. J J Patel & Associates as Internal Auditor for FY 2026-27. The appointment was approved during a board meeting.
Global Longlife Hospital approved its 15th AGM notice and director re-appointments. Key resolutions include re-appointing Mr. Dhruv Jani as Managing Director for a five-year term.
Global Longlife Hospital and Research Ltd reported a net loss of ₹0.4 Cr for H2 FY26.
Global Longlife Hospital and Research Limited reported its FY26 audited financial results, showing total income of ₹0.52 Lakhs and a net loss of ₹171.95 Lakhs. The Board also approved an alteration of the company's name and main object clause to transition from healthcare to the trade and service industry, subject to shareholder and regulatory approvals.
Global Longlife Hospital and Research Limited has scheduled a Board Meeting for May 07, 2026. The board will consider audited financial results for the year ended March 31, 2026, a proposed company name change, and alterations to the Memorandum of Association. The trading window remains closed for designated persons.
Global Longlife Hospital and Research Ltd confirmed it does not meet the SEBI criteria for 'Large Corporate' status for FY 2025-26. The company reported zero incremental borrowings and no mandatory debt security issuance requirements for the period.
Global Longlife Hospital and Research Ltd clarified that the submission of the Annual Secretarial Compliance Report under SEBI Regulation 24(A) is not applicable. This exemption applies as the company's equity shares are listed on the BSE SME Platform. The clarification pertains to the financial year ended March 31, 2026.